Published in Healthcare Finance, Tax and Law Weekly, February 7th, 2007
This trend article about GlaxoSmithKline, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Data detailed in "Functional characterization of an orphan nuclear receptor, Rev-ErbAalpha, in chondrocytes and its potential role in osteoarthritis" have been presented. In this recent study, researchers in the United States conducted a study "To evaluate the expression and function of the orphan nuclear receptor Rev-ErbAalpha in articular cartilage and to investigate its role in osteoarthritis (OA). Expression of Rev-ErbAalpha was analyzed at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.